E.Yu. Evdokimov, Zh.B. Ponezheva, E.V. Svechnikova, B.M. Gruzdev, A.D. Meshkov, V.S. Pykhtina
The role of systemic inflammation in HIV-infected patients with moderate and severe psoriasis
|
№10 / 2022
|
L.V. Vasilyeva (1), E.N. Bezzubtseva (1), E.F. Evstratova (1), E.V. Gosteva (1), I.B. Zubkova (2)
Clinical significance of genetic and inflammatory markers of bone metabolism in patients with chronic obstructive pulmonary disease and osteoporosis
|
№5 / 2021
|
N.S. Alekseeva (1), E.V. Beloborodova (2)
The effectiveness of therapeutic measures in metabolic syndrome and vitamin d deficiency
|
№4 / 2019
|
S.A. Smakotina (1), A.R. Zelendinova (1), I.N. Bondareva (2), N.V. Fomina (1), S.A. Berns (3), A.A. Golikova (3)
ATORVASTATIN IN THE PREVENTION OF CARDIOVASCULAR DISEASES IN FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS
|
№9 / 2017
|
Yu.A. Bochenina, G.E. Kuznetsov, L.R. Tenchurina
DYNAMICS OF THE MARKERS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE DURING TREATMENT WITH ROSUVASTATIN
|
№20 / 2013
|